Non-Clinical Drug Safety Evaluation in Drug and Biologic Development

בהדרכת: Dr. Shayne Gad
גרסה להדפסה

שתף קולגה:

This course provides a comprehensive explanation of the non-clinical development of drugs, biologics and combination products, emphasizing the principles of pharmaceutical toxicology and the assessment of product safety.  In addition to the different types of toxicity studies in modern pharmaceutical development, it also describes the relationship between pharmacology, clinical trial design, regulatory strategy and project management.

...המשך קריאה

This course provides a comprehensive explanation of the non-clinical development of drugs, biologics and combination products, emphasizing the principles of pharmaceutical toxicology and the assessment of product safety.  In addition to the different types of toxicity studies in modern pharmaceutical development, it also describes the relationship between pharmacology, clinical trial design, regulatory strategy and project management.

Emphasis will be placed on how safety assessment (“toxicology”) studies are integrated into the multidisciplinary development plans of new drugs and biologics, and how they affect development decisions.  Regulatory affairs will be covered, and descriptions given of the European and the U.S. FDA requirements, the new drug review process, and common regulatory errors.

סגור
תאריכים: 
  • 22/01/2020
  • 23/01/2020

מתעניינים? לחצו כאן

    מיקום הקורס: מלון דיויד אינטרקונטיננטל, פרופסור יחזקאל קויפמן 12, תל אביב
    משך הפעילות: 2 ימי לימוד. 4 מפגשים, 4 ש"ל כל מפגש
    שעות: 17:00 - 09:00
    נקודות זכות: 2
    שפת הקורס: עברית

    עלות הקורס המלאה: ₪1,700 כולל מע"מ
    ההרשמה המוזלת נסגרה
    יש לך מנוי? מגיעה לך הנחה נוספת!

    יש לך שאלה? יש לנו את כל התשובות

    מה תכני הקורס?

    Day 1

    Drugs and Biologics:

    • A. Overview of the Drug Development Process
    • B. Toxicological Manifestations/Mechanisms/Endpoints (Tox M, M, & E)
    • C. Paths to Market Approval – The Kinds of NDAs
    • D. Pilot Studies (MTD’s and DRF’s)
    • E. Repeat-dose Toxicity Studies
      • Test Item Calculator
    • F. Nonclinical dose selection
    • G. Genotoxicity Studies
    • H. Safety Pharmacology Studies for Human Pharmaceuticals
    • I. Toxicokinetics and Pharmacokinetics
    EVENING SESSION: Contracting Studies to Outside Labs

    Day 2

    • J. Carcinogenicity Studies
    • K. Local Tissue Tolerance
    • L. Reproduction and Development Toxicity Studies
    • M. Additional Special Studies: Immunotoxicology, Dermal Sensitization, and Phototoxicity
    • N. Safety Testing of Biotechnology Derived Products
    • O. Formulations and Excipients
    • P. Impurities and Degradents
    • Q. Assessing the safety of oncology, gene therapy, vaccine, and antibiotic products
    • Appendix A    Acronyms
    • Appendix B    Definition of Terms and Lexicon of "Clinical" Observations in Nonclinical (Animal) Studies
    • Appendix C    Notable Regulatory Internet Addresses
    • Appendix D   Nonclinical Drug Toxicology CRO’s

    למי זה מתאים?

    • Scientists who wish to gain an understanding of pharmaceutical toxicity studies
    • Managerial personnel
    • Project management staff
    • Regulatory Scientists involved in preclinical development
    • Investors

     

    מה אקבל מכך בפועל?

    Participants will complete this course with an in depth understanding of a working knowledge of pharmaceutical toxicology and drug development to enable you to develop new drugs faster and more efficiently.

    • Address the strategic, scientific and regulatory concerns for the non-clinical development of drugs, biologics and combination products
    • Determine how toxicology studies fit into the multi-disciplinary development scheme for new drug development and influence development strategies
    • Better prepare yourself for a wide range of positions in pharmaceutical R&D

    מי מעביר את הקורס?

    Shayne Gad
    Shayne C. Gad, B.S. (Whittier College, Chemistry and Biology, 1970)
    Read more

    הוספת תגובה

      אנא חזרו אלי